Midgard Science

Quinta-Analytica

Prague, Czechia quinta.cz From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

Quinta-Analytica is a GxP-certified CRO that provides analytical development, quality control, clinical studies, bioanalysis, and related regulatory support for small molecules, biologics, biosimilars, and veterinary and human medicinal products. It operates from Prague, Brno, and Ostrava in the Czech Republic and serves global projects under GxP quality systems. The company also offers API sourcing and audit support.

Services

  • Pharmaceutical Analyses

    Validates analytical methods, performs quality control, stability studies, batch release, and related pharmaceutical testing.

  • Clinical Testing

    Runs in-house BA/BE/PK clinical studies in two clinical units.

  • Bioanalytical Testing

    Provides bioanalysis for preclinical and clinical studies through Phase III, including statistical evaluation.

  • Analytical R&D

    Develops and validates analytical methods, and conducts impurities research, degradation studies, and trace analyses.

  • Biologics Quality Control

    Provides analytical services for large molecules, including validation of bioanalytical methods in a GxP environment and method transfer.

  • Nitrosamines Analysis

    Offers customizable in-house nitrosamine detection methods based on isotopically labeled standards.

  • Monitoring of Studies

    Oversees participant health and the correctness of treatments during clinical studies.

  • Pharmacovigilance

    Monitors routine activity to detect unrecognized adverse events and assess drug safety.

3 more services
  • Module 3 Audit
  • IMPD Compilation
  • API Solution

Capabilities

Assays and studies
  • Bioanalysis
  • Cell-based assays
  • HPLC
  • Analytical development
  • Stability studies
  • Small molecules
12 more
  • PK/PD
  • Analytical method validation
  • Quality control
  • Batch release
  • BA studies
  • BE studies
  • PK studies
  • Impurities research
  • Degradation studies
  • Trace analysis
  • Nitrosamine analysis
  • Statistical evaluation
Scale and capacity
  • Two clinical units
  • Over 300 BA/BE/PK studies completed

Instruments and platforms

  • HPLC

Modalities and species

Modalities
  • Small molecule
  • Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

  • GMPSelf-reported

    Scope: human medicinal products

Company

Type
CRO
Founded
1996

Locations

Office
During 2008, he became the CFO of Eczacibasi-Zentiva Turkey. Later, dur
Sites
  • Brno, Czech Republic
  • Ostrava, Czech Republic
Serves
Global

Contacts

Public records

Parent company
QUINTA-ANALYTICA s.r.o. · CZ GLEIF
FDA drug establishment registration
3005363495 · ANALYSIS source

Similar labs